Guardion Health Sciences, Inc. - Common Stock (GHSI)
3.2500
0.00 (0.00%)
Guardion Health Sciences Inc is a company focused on the development and commercialization of innovative health and wellness solutions, particularly in the field of eye health
The company emphasizes the importance of nutritional support and advanced diagnostics, aiming to provide patients and healthcare providers with products that improve visual function and overall well-being. By leveraging research and technology, Guardion is dedicated to addressing medical conditions related to vision and enhancing the quality of life for individuals through tailored health products and services.
Guardion Health Sciences shares are trading lower by 38% during Tuesday's session. The company announced it adopted a plan of dissolution and liquidation.
GHSI stock results show that Guardion Health Sciences missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
GHSI stock results show that Guardion Health Sciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Shares of Tilray Brands, Inc. (NASDAQTLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free
After the market close on Tuesday, Guardion announced it had signed an equity purchase agreement to sell its Activ Nutritional subsidiary to Doctor's Best Inc., a wholly-owned subsidiary of Kingdomway USA Corp., for gross cash consideration of $17.2 million, payable in full at closing.
Gainers Akumin Inc. (NASDAQAKU) shares surged 58.2% to $0.2865 in pre-market trading. Akumin recently named Krishna Kumar as President and Chief Operating Officer of the Company.
Gainers CinCor Pharma, Inc. (NASDAQCINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
